Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2002
10/10/2002US20020147195 Piperidine derivatives and anti-platelet agents containing the same
10/10/2002US20020147194 Psychological disorders; antiserotonin agents; headache therapy
10/10/2002US20020147192 Viricides; antiinflammatory agents; antiallergens; antiarthritic agents
10/10/2002US20020147189 Immunology response; autoimmune disease
10/10/2002US20020147188 Protease inhibitors
10/10/2002US20020147185 Antihypoxic agents, antiischamic agents, antiarrhythmia agents
10/10/2002US20020147184 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
10/10/2002US20020147180 Stable amorphous amifostine compositions and methods for the preparation of same
10/10/2002US20020147160 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
10/10/2002US20020147158 Composition and method for preventing and treating sinusoidal obstruction syndrome and radiation-induced liver disease
10/10/2002US20020147144 Prevention, therapy autoimmune diseases; anticholesterol agents
10/10/2002US20020147139 Viricides
10/10/2002US20020147138 Anticancer agents
10/10/2002US20020147129 Polypeptides; nervous system, brain disorders
10/10/2002US20020146821 Bone marrow cells as a source of neurons for brain and spinal cord repair
10/10/2002US20020146819 Human TSLP DNA and polypeptides
10/10/2002US20020146805 DNA encoding the human serine protease T
10/10/2002US20020146802 Methods for producing and purifying recombinant alpha-L-iduronidase
10/10/2002US20020146797 Genetically engineered enzyme for use in the treatment of cell proliferative disorders
10/10/2002US20020146791 Corpuscles of stannius protein, stanniocalcin
10/10/2002US20020146774 Smad2 phosphorylation and interaction with Smad4
10/10/2002US20020146773 ''Signalin'' family of TGFbeta signal transduction proteins, and uses related thereto
10/10/2002US20020146770 RAS proteins
10/10/2002US20020146768 Apoliprotein for use in treatment of stroke, heart defects, reperfusion injuries, viral, nervous system, vision and blood disorders
10/10/2002US20020146760 G protein-coupled receptor for use in treatment of alzheimer's disease
10/10/2002US20020146759 Stress proteins and peptides and methods of use thereof
10/10/2002US20020146463 Useful as food additives or in medicaments
10/10/2002US20020146462 Anti-tumor therapies comprising a combination of a cartilage extract and an anti-neoplastic agent providing high efficacy and low toxic side effects
10/10/2002US20020146454 Active compound is prepared in aqueous solution/ suspension; sprayed onto neutral excipients, without isolating active compound as solid substance, and dried in parallel with this, or, mixing with binder granulating with excipients and drying
10/10/2002US20020146453 For sustained release; therapy
10/10/2002US20020146450 Liposome-entrapped topoisomerase inhibitors
10/10/2002US20020146431 For prophylaxis of porcine multisystemic wasting syndrome (PMWS)
10/10/2002US20020146408 Human haemopoietic maturation factor
10/10/2002US20020146390 Therapy of sepsis and adult respiratory distress syndrome using chemokine or biologically active fragment thereof, alone or in conjunction with an anti-infective agent
10/10/2002DE10117204A1 In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel In the 6-position substituted indolinones, their preparation and their use as medicaments
10/10/2002DE10117183A1 Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel Use of substituted imidazo [1,2-a] -pyridinverbindungen as medicaments
10/10/2002DE10116589A1 Use of creatine for reducing oxidative stress e.g. for treating aging, neurodegeneration and cancers
10/10/2002DE10115073A1 Verwendung von Inhibitoren von IKK-ß und Verfahren zum Auffinden solcher Inhibitoren Use of inhibitors of IKK-ß and methods for finding such inhibitors
10/10/2002DE10114775A1 2-Mercapto-4,5-diarylimidazolderivate und ihre Verwendung in der Pharmazie 2-mercapto-4,5-diarylimidazolderivate and their use in the pharmaceutical
10/10/2002CA2443050A1 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002CA2442684A1 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
10/10/2002CA2442531A1 Peptides and antibodies to muc 1 proteins
10/10/2002CA2442525A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002CA2442495A1 Alpha conotoxin peptides with analgesic properties
10/10/2002CA2442481A1 3-heterocyclylpropanohydroxamic acid as procollagen c-proteinase inhibitors
10/10/2002CA2442476A1 Pyridazinone aldose reductase inhibitors
10/10/2002CA2442455A1 A method of treating proliferative diseases using eg5 inhibitors
10/10/2002CA2442428A1 Novel tyrosine kinase inhibitors
10/10/2002CA2442410A1 Duloxetine for treatment of hot flashes
10/10/2002CA2442354A1 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
10/10/2002CA2442330A1 Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning
10/10/2002CA2441970A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
10/10/2002CA2441654A1 Cytoskeleton-associated proteins
10/10/2002CA2441335A1 Synergistic combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer
10/10/2002CA2441252A1 Estrogen replacement therapy
10/10/2002CA2441077A1 Substituted carbazoles as inhibitors of spla2
10/10/2002CA2440228A1 Inhibitors of cyclin dependent kinases as anti-cancer agent
10/10/2002CA2439842A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
10/10/2002CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002CA2438210A1 Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds
10/10/2002CA2437789A1 Topical composition comprising an antifungal
10/10/2002CA2437113A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/10/2002CA2429108A1 .psi..epsilon.rack peptide composition and method for protection against tissue damage due to ischemia
10/09/2002EP1247865A2 Antibody for use in therapy
10/09/2002EP1247860A1 Crystal structure of pyruvate dehydrogenase kinase 2 (PDHK-2) and use thereof in methods for identifying and designing new ligands
10/09/2002EP1247810A1 Novel benzotriazoles anti-inflammatory compounds
10/09/2002EP1247809A2 Triazine compounds useful as sorbitol dehydrogenase inhibitors
10/09/2002EP1247803A2 Indolinone compounds suitable for modulation of protein kinases
10/09/2002EP1247533A2 Combination treatment of multiple sclerosis (MS), other demyelinating conditions and peripheral neuropathy, especially painful neuropathies and diabetic neuropathy
10/09/2002EP1247532A1 Composition promoting lacrimal secretion
10/09/2002EP1247531A2 TNF-derived peptides for use in treating oedema
10/09/2002EP1247527A1 Cosmetic and/or pharmaceutical preparations containing extracts of the plant Litchi chinensis Sonn
10/09/2002EP1247525A1 Use of a monosaccharide in the manufacture of a medicament against acute mountain sickness
10/09/2002EP1247524A1 Composition comprising taurolidine and/or taurultam for the treatment of cancer
10/09/2002EP1246946A2 Compositions and methods for the discovery and selection of biological information
10/09/2002EP1246940A2 Chemotherapeutant screening method
10/09/2002EP1246931A1 Compositions comprising nucleic acids incorporated in bilaminar mineral particles
10/09/2002EP1246925A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/09/2002EP1246923A2 Dna modification proteins
10/09/2002EP1246920A2 Prevention of affections associated with porcine circovirus-2
10/09/2002EP1246919A1 Progenitor cell preservation factors and related methods and products
10/09/2002EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies
10/09/2002EP1246840A2 Human and parasite orphan receptor proteins
10/09/2002EP1246839A1 Depsipeptide and congeners thereof for use as immunosuppressants
10/09/2002EP1246835A2 Substituted sapogenins and their use
10/09/2002EP1246828A1 Benzosulfones with calcium antagonist activity
10/09/2002EP1246825A1 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof
10/09/2002EP1246824A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof
10/09/2002EP1246823A1 Pyrimidine and triazine kinase inhibitors
10/09/2002EP1246820A1 Novel heteroaryl derivatives, their preparation and use
10/09/2002EP1246818A1 Novel indole derivatives
10/09/2002EP1246816A1 Substituted phenyl-piperazine derivatives, their preparation and use
10/09/2002EP1246809A1 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
10/09/2002EP1246808A1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
10/09/2002EP1246806A1 Arly- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
10/09/2002EP1246805A1 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
10/09/2002EP1246804A1 4-carboxyamino-2-ethyl-1,2,3,4-tetrahydroquinoline crystal as cetp inhibitor
10/09/2002EP1246800A1 Beta-amino acid compounds as integrin antagonists
10/09/2002EP1246792A1 Compounds and compositions for delivering active agents
10/09/2002EP1246692A1 Templating of solid particles by polymer multilayers
1 ... 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 ... 1564